• Users Online: 111
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2019  |  Volume : 28  |  Issue : 3  |  Page : 218-223

Dyslipidaemia in hypertension - are we treating enough?


1 Department of Chemical Pathology, College of Medicine, University of Nigeria, Enugu Campus, Enugu State, Nigeria
2 Department of Radiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria
3 Department of Community Medicine, College of Medicine, University of Nigeria, Enugu Campus, Enugu State, Nigeria
4 Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria

Correspondence Address:
Ijeoma A Meka
Department of Chemical Pathology, College of Medicine, University of Nigeria Enugu Campus, Enugu State
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1115-2613.278589

Rights and Permissions

INTRODUCTION: The coexistence of dyslipidaemia and hypertension results in enhanced atherosclerosis. Adequate treatment of dyslipidaemia in hypertensive patients is thus essential for reducing the burden of cardiovascular diseases. OBJECTIVE: To determine the prevalence of dyslipidaemia among hypertensives and evaluate lipid treatment status of patients with dyslipidaemia in a tertiary hospital in Nigeria. METHODS: This cross-sectional comparative study was done between May, 2015 and June, 2016 in a tertiary hospital in Nigeria. The serum lipid levels of adult patients with hypertension and controls without hypertension were determined. Lipid treatment status of patients with dyslipidaemia were also reviewed. Serum lipid levels were analyzed using spectrophotometric methods. RESULTS: The study included 200 adult hypertensive patients and 100 control participants. The mean age (SD) was 56.3 (6.9) years and 54.9 (8.3) years with range 41-68 and 44-69 years for patients and controls respectively. Eighty-eight (44.0%) hypertensive patients and 23(23.5%) of the control group were found to have dyslipidaemia. Out of the 60(68.2%) patients with elevated LDL-C, 32(53.3%) had LDL-C >4.1mmol/L, out of which only 8(25%) were on antilipid medication. CONCLUSION: Over one-third of studied hypertensive patients had dyslipidaemia and only a quarter of those who needed antilipids were on the medication. Greater awareness is needed both in the medical and patient communities in order to effectively manage dyslipidaemic hypertension, and hence aid in ameliorating the burden of cardiovascular diseases.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed44    
    Printed5    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal